首页> 外文期刊>Bulletin of experimental biology and medicine >Autoantibodies to neuron-specific proteins S100, GFAP, MBP and NGF in the serum of rats with streptozotocin-induced diabetes
【24h】

Autoantibodies to neuron-specific proteins S100, GFAP, MBP and NGF in the serum of rats with streptozotocin-induced diabetes

机译:链脲佐菌素诱发的糖尿病大鼠血清中神经元特异性蛋白S100,GFAP,MBP和NGF的自身抗体

获取原文
获取原文并翻译 | 示例
           

摘要

The appearance of autoantibodies to neuronal proteins (S100, GFAP, MBP, and NGF) in rat serum was analyzed by ELISA on days 5, 10, 17, 25, and 32 after streptozotocin injection. Simultaneously, blood glucose and insulin autoantibodies were assayed. Serum glucose level increased on the next day after streptozotocin injection and the level of autoantibodies to insulin significantly increased on day 5 indicating the development of diabetes. The levels of antibodies to specific neuronal proteins (S100, GFAP, MBP, and NGF) also increased at this term. It is concluded that diabetes with streptozotocin is associated with damage to the blood-brain barrier.
机译:在注射链脲佐菌素后第5、10、17、25和32天,通过ELISA分析大鼠血清中神经元蛋白(S100,GFAP,MBP和NGF)的自身抗体的出现。同时,测定血糖和胰岛素自身抗体。注射链脲佐菌素后的第二天,血清葡萄糖水平增加,并且对胰岛素的自身抗体水平在第5天显着增加,表明糖尿病的发展。在此期间,针对特定神经元蛋白(S100,GFAP,MBP和NGF)的抗体水平也有所提高。结论是带有链脲佐菌素的糖尿病与血脑屏障的损害有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号